Skip to main content

Market Overview

A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data

Share:
A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data

Pre-open movers

U.S. stock futures traded higher in early pre-market trade. Data on durable goods orders and the Chicago Fed National Activity Index for November will be released at 8:30 a.m. ET. Data on new home sales for November will be released at 10:00 a.m. ET.

Futures for the Dow Jones Industrial Average gained 35 points to 28,517 while the Standard & Poor’s 500 index futures traded rose 5.1 points to 3,230.75. Futures for the Nasdaq 100 index gained 17.75 points to 8,728.50.

Oil prices traded lower as Brent crude futures fell 1.4% to trade at $65.21 per barrel, while US WTI crude futures fell 0.2% to trade at $60.33 a barrel.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index falling 0.2%, STOXX Europe 600 Index climbing 0.1% and German DAX 30 index dropping 0.2%. The UK's FTSE index was trading higher by 0.4%, while French CAC 40 Index rose 0.1%.

In Asian markets, Japan’s Nikkei Stock Average rose 0.02%, Hong Kong’s Hang Seng Index gained 0.13%, China’s Shanghai Composite Index fell 1.4% and India’s BSE Sensex fell 0.1%.

Broker Recommendation

Analysts at JP Morgan upgraded 3M Company (NYSE: MMM) from Underweight to Neutral and raised the price target from $143 to $150.

3M shares rose 0.6% to $176.38 in pre-market trading.

Breaking News

  • Sarepta Therapeutics, Inc. (NASDAQ: SRPT) reported a partnership with Roche in territories outside the United States for its investigational micro-dystrophin gene therapy for duchenne muscular dystrophy, SRP-9001.
  • Bunge Ltd (NYSE: BG) agreed to sell its margarine and mayonnaise assets in Brazil to Seara Alimentos S.A.
  • DavidsTea Inc (NASDAQ: DTEA) reported a Q3 loss of $0.34 per share, versus a year-ago loss of $0.33 per share.
  • BeiGene, Ltd. (NASDAQ: BGNE) reported the acceptance of a supplemental NDA in China for REVLIMID in relapsed or refractory indolent lymphoma.
 

Related Articles (BG + BGNE)

View Comments and Join the Discussion!

Posted-In: A Peek Into The MarketsEarnings News Eurozone Commodities Global Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com